糖尿病肥胖与代谢 SCIE

期刊简介预计审稿时间： 一般,3-8周

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

《糖尿病、肥胖和代谢》主要刊登临床和实验药理学和治疗学杂志，涵盖糖尿病、肥胖和代谢相关领域。该杂志优先刊登高质量的原创研究，报告新疗法或现有疗法（包括饮食、运动和生活方式（非药物）干预）对人类或动物和细胞系统代谢和内分泌疾病任何方面的影响。“代谢”可能与脂质、骨骼和药物代谢或内分泌功能障碍的更广泛方面有关。临床前药理学、药代动力学研究、荟萃分析以及涉及药物安全性和耐受性的研究也非常适合在该杂志上发表。原创研究可以作为主要论文或研究信函发表。

《Diabetes Obesity & Metabolism》(糖尿病肥胖与代谢)编辑部通讯方式为WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。